Myomo, Inc.

NYSE American MYO

Myomo, Inc. Free Cash Flow Yield on January 14, 2025: -4.44%

Myomo, Inc. Free Cash Flow Yield is -4.44% on January 14, 2025, a 25.19% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Myomo, Inc. 52-week high Free Cash Flow Yield is -3.84% on January 07, 2025, which is 13.46% above the current Free Cash Flow Yield.
  • Myomo, Inc. 52-week low Free Cash Flow Yield is -11.54% on July 02, 2024, which is -160.10% below the current Free Cash Flow Yield.
  • Myomo, Inc. average Free Cash Flow Yield for the last 52 weeks is -7.12%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
NYSE American: MYO

Myomo, Inc.

CEO Mr. Paul R. Gudonis
IPO Date June 12, 2017
Location United States
Headquarters 137 Portland Street
Employees 101
Sector Technology
Industries
Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Similar companies

IRIX

IRIDEX Corporation

USD 1.61

-1.23%

SSKN

STRATA Skin Sciences, Inc.

USD 2.95

0.00%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

VVOS

Vivos Therapeutics, Inc.

USD 5.06

4.33%

NXL

Nexalin Technology, Inc.

USD 2.78

10.76%

BJDX

Bluejay Diagnostics, Inc.

USD 3.36

-7.95%

NUWE

Nuwellis, Inc.

USD 1.05

3.96%

HSCS

Heart Test Laboratories, Inc.

USD 3.26

1.24%

SINT

Sintx Technologies, Inc.

USD 3.21

-4.46%

RSLS

ReShape Lifesciences Inc.

USD 4.66

-6.80%

NVNO

enVVeno Medical Corporation

USD 3.14

-1.57%

StockViz Staff

January 15, 2025

Any question? Send us an email